Celularity Inc (CELU) income statement
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.47−0.02 (-3.15%)
Close on Nov 19, 2026Market cap $15.18MP/E –Yield –
Celularity Inc financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $15.18MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | 24.4% | 72.4% | 29.7% | -9.4% | 54.8% | 65.5% | – | – |
| Operating margin | -230.9% | -70.7% | -844.4% | -142.4% | -511.2% | -1,064.0% | – | – |
| EBITDA margin | -203.4% | -56.1% | -803.5% | -89.9% | -469.8% | -1,006.8% | – | – |
| Pre-tax margin | -345.4% | -106.8% | -862.0% | 79.0% | -469.2% | -1,491.3% | – | – |
| Net profit margin | -345.4% | -106.8% | -862.0% | 79.0% | -469.3% | -1,458.4% | – | – |
| Free cash flow margin | – | -12.1% | -174.5% | -796.2% | -545.1% | -637.5% | – | – |
| Effective tax rate | – | – | – | 0.09% | – | – | 10.2% | – |
| Returns on capital | ||||||||
| Return on equity | 628.2% | -232.5% | -163.7% | 9.5% | 46.4% | 0.92% | 0.13% | – |
| Return on assets | -76.4% | -41.9% | -72.0% | 3.5% | -23.7% | -57.6% | 4.0% | – |
| Return on tangible assets | -87.4% | -47.6% | -77.2% | 8.5% | -56.9% | -184.9% | 31.2% | – |
| Return on invested capital | 464.6% | – | -109.4% | -12.3% | – | – | – | – |
| Return on capital employed | -116.1% | -49.3% | -92.5% | -7.0% | -27.5% | -43.7% | -1.2% | – |
| Return on total capital | 1,442.5% | – | -121.4% | -10.8% | – | – | – | – |
| NOPAT | -$48.43M | -$30.30M | -$151.91M | -$25.58M | -$86.16M | -$120.02M | -$1.51M | – |
| Cash flow quality | ||||||||
| OCF / Sales | -49.9% | -11.8% | -169.9% | -767.0% | -516.0% | -442.6% | – | – |
| OCF / Net income | 0.14 | 0.11 | 0.20 | -9.72 | 1.10 | 0.30 | -0.19 | – |
| FCF / OCF | – | 102.5% | 102.7% | 103.8% | 105.6% | 144.0% | – | – |
| FCF / Net income | – | 0.11 | 0.20 | -10.08 | 1.16 | 0.44 | – | – |
| FCF / EBITDA | – | 21.6% | 21.7% | 885.4% | 116.0% | 63.3% | – | – |
| Unlevered free cash flow | – | -$6.56M | -$39.73M | -$143.11M | -$116.30M | -$91.03M | – | – |
| Levered free cash flow | – | -$6.56M | -$39.73M | -$143.11M | -$116.30M | -$91.03M | – | – |
| Efficiency | ||||||||
| Asset turnover | 0.22 | 0.39 | 0.08 | 0.04 | 0.05 | 0.04 | – | – |
| Fixed asset turnover | 0.45 | 0.84 | 0.32 | 0.22 | 0.24 | 0.16 | – | – |
| Receivables turnover | 5.71 | – | – | – | – | – | – | – |
| Days sales outstanding | 64.0 | – | – | – | – | – | – | – |
| Payables turnover | 0.81 | 0.80 | 1.61 | – | – | – | – | – |
| Days payables outstanding | 452.0 | 455.9 | 227.4 | – | – | – | – | – |
| Inventory turnover | 6.71 | 2.69 | 2.90 | – | – | – | – | – |
| Days inventory outstanding | 54.4 | 135.9 | 126.0 | – | – | – | – | – |
| Operating cycle | 118.3 | – | – | – | – | – | – | – |
| Cash conversion cycle | -333.7 | – | – | – | – | – | – | – |
| CapEx to revenue | – | 0.30% | 4.6% | 29.1% | 29.1% | 194.9% | – | – |
| CapEx to OCF | – | -2.5% | -2.7% | -3.8% | -5.6% | -44.0% | – | – |
| CapEx to depreciation | – | 0.02 | 0.11 | 0.55 | 0.70 | 3.41 | – | – |
| Liquidity | ||||||||
| Current ratio | 0.15 | 0.38 | 0.29 | 0.54 | 2.25 | 2.70 | 4.40 | 0.16 |
| Quick ratio | 0.15 | 0.28 | 0.21 | 0.45 | 1.89 | 2.35 | 4.40 | 0.16 |
| Cash ratio | 0.08 | 0.20 | 0.15 | 0.46 | 1.99 | 2.61 | 189.91 | 0.16 |
| Working capital | -$68.44M | -$33.12M | -$47.51M | -$28.59M | $32.88M | $45.48M | $780.06K | -$125.85K |
| Net current asset value | -$133.07M | -$103.28M | -$83.14M | -$168.66M | -$255.61M | -$340.14M | -$27.20M | -$125.85K |
| Leverage | ||||||||
| Total debt | $33.81M | – | $39.24M | $37.60M | – | – | – | – |
| Net debt | $27.64M | – | $29.08M | $8.80M | – | – | – | – |
| Debt / Equity | -0.89 | – | 0.96 | 0.19 | – | – | – | – |
| Debt ratio | 31.5% | – | 27.3% | 9.4% | – | – | – | – |
| Assets to equity | -2.82 | 15.01 | 3.51 | 2.02 | 4.17 | -0.81 | -0.89 | 7.30 |
| Long-term debt to assets | 31.5% | – | – | – | – | – | – | – |
| Long-term debt to equity | -0.89 | – | – | – | – | – | – | – |
| Total debt / Capitalization | -795.6% | – | 48.9% | 15.9% | – | – | – | – |
| Long-term debt / Capitalization | -795.6% | – | – | – | – | – | – | – |
| Net debt / EBITDA | -0.51 | – | -0.16 | -0.54 | – | – | – | – |
| Total debt / EBITDA | -0.63 | – | -0.21 | -2.33 | – | – | – | – |
| Cash flow to debt | -39.2% | – | -98.6% | -366.7% | – | – | – | – |
| Goodwill / Assets | 6.8% | 5.5% | 5.1% | 29.8% | 29.8% | 28.6% | 43.6% | – |
| Intangibles to total assets | 14.1% | 12.5% | 12.8% | 60.0% | 59.5% | 57.7% | 43.6% | – |
| Per share | ||||||||
| Revenue per share | 0.92 | 2.40 | 1.18 | 1.21 | 1.72 | 7.71 | – | – |
| EPS (basic) | -3.59 | -2.64 | -11.02 | 1.01 | -14.90 | -113.10 | 0.33 | – |
| EPS (diluted) | -3.59 | -2.64 | -11.02 | 0.95 | -14.90 | -113.10 | 0.33 | – |
| Book value per share | -1.32 | 0.39 | 2.11 | 13.36 | 8.00 | -286.79 | -344.67 | – |
| Tangible book value per share | -1.84 | -0.34 | 1.17 | -2.81 | -11.83 | -421.00 | -478.43 | – |
| Cash per share | 0.21 | 0.49 | 0.52 | 1.93 | 4.19 | 37.51 | 45.80 | – |
| Operating cash flow per share | -0.46 | -0.28 | -2.00 | -9.26 | -8.86 | -34.10 | -1.16 | – |
| Free cash flow per share | – | -0.29 | -2.05 | -9.61 | -9.36 | -49.13 | – | – |
| CapEx per share | – | 0.0071 | 0.05 | 0.35 | 0.50 | 15.02 | – | – |
| Valuation at period end | ||||||||
| Market cap | $31.32M | $45.73M | $47.91M | $186.44M | $632.14M | – | – | – |
| Enterprise value | $66.87M | $78.01M | $46.82M | $168.21M | $544.70M | – | – | – |
| P/E | – | – | – | 13.1x | – | – | – | – |
| P/S | 1.2x | 0.8x | 2.1x | 10.4x | 29.6x | – | – | – |
| P/B | -0.8x | 5.2x | 1.2x | 0.9x | 6.4x | – | – | – |
| P/TBV | -0.6x | -5.9x | 2.1x | -4.5x | -4.3x | – | – | – |
| P/Gross profit | 4.8x | 1.2x | 7.1x | -110x | 54.1x | – | – | – |
| P/OCF | -2.4x | -7.1x | -1.2x | -1.4x | -5.7x | – | – | – |
| EV/Sales | 2.5x | 1.4x | 2.1x | 9.4x | 25.5x | – | – | – |
| EV/Gross profit | 10.3x | 2.0x | 6.9x | -99.5x | 46.6x | – | – | – |
| EV/OCF | -5.0x | -12.2x | -1.2x | -1.2x | -4.9x | – | – | – |
| Earnings yield | -292.8% | -126.6% | -409.7% | 7.6% | -15.8% | – | – | – |
| FCF yield | – | -14.4% | -82.9% | -76.8% | -18.4% | – | – | – |
| Cost structure | ||||||||
| R&D to revenue | 56.6% | 32.1% | 133.8% | 436.0% | 414.1% | 369.1% | – | – |
| SG&A to revenue | 193.1% | 108.2% | 222.1% | 367.3% | 334.4% | 219.5% | – | – |
| Stock-based comp to revenue | 40.1% | 21.3% | 0.00% | 88.2% | 187.5% | 30.6% | – | – |
| Per employee | ||||||||
| Total employees | 115 | 123 | 120 | 225 | 225 | 225 | 225 | 225 |
| Revenue per employee | $230.87K | $440.81K | $189.76K | $79.89K | $94.82K | $63.46K | – | – |
| Gross profit per employee | $56.31K | $318.95K | $56.29K | -$7.51K | $51.92K | $41.54K | – | – |
| Operating profit per employee | -$533.11K | -$311.85K | -$1.60M | -$113.78K | -$484.71K | -$675.22K | -$7.48K | – |
| Net income per employee | -$797.53K | -$470.67K | -$1.64M | $63.08K | -$444.97K | -$925.48K | $26.13K | – |
| Free cash flow per employee | – | -$53.35K | -$331.11K | -$636.05K | -$516.88K | -$404.56K | – | – |
| Growth | ||||||||
| Revenue 1Y growth | -51.0% | 138.1% | 26.7% | -15.7% | 49.4% | – | – | – |
| Revenue 3Y CAGR | 13.9% | 36.5% | 16.8% | – | – | – | – | – |
| Revenue 5Y CAGR | 13.2% | – | – | – | – | – | – | – |
| Gross profit 1Y growth | -83.5% | 480.8% | 499.7% | -114.5% | 25.0% | – | – | – |
| Gross profit 3Y CAGR | – | 49.8% | -10.3% | – | – | – | – | – |
| Gross profit 5Y CAGR | -7.1% | – | – | – | – | – | – | – |
| EBIT 1Y growth | -59.8% | 80.1% | -651.1% | 76.5% | 28.2% | -8,924.1% | – | – |
| EBITDA 1Y growth | -77.5% | 83.4% | -1,031.9% | 83.9% | 30.3% | – | – | – |
| Net income 1Y growth | -58.4% | 70.5% | -1,483.1% | 114.2% | 51.9% | -3,642.1% | – | – |
| Net income 3Y CAGR | – | – | – | 34.1% | – | – | – | – |
| Diluted EPS 1Y growth | -36.0% | 76.0% | -1,260.0% | 106.4% | 86.8% | -34,030.0% | – | – |
| Diluted EPS 3Y CAGR | – | – | – | 41.8% | – | – | – | – |
| Operating cash flow 1Y growth | -107.1% | 83.5% | 71.9% | -25.2% | -74.2% | -5,656.2% | – | – |
| Free cash flow 1Y growth | – | 83.5% | 72.2% | -23.1% | -27.8% | – | – | – |
| CapEx 1Y growth | – | -84.6% | -80.0% | -15.6% | -77.7% | – | – | – |
| CapEx 3Y CAGR | – | -70.4% | -66.5% | – | – | – | – | – |
| Total assets 1Y growth | -19.1% | -7.8% | -64.1% | -3.2% | -3.9% | 47.8% | 167,050.3% | – |
| Total assets 3Y CAGR | -35.6% | -31.6% | -30.6% | 11.2% | 1,234.0% | – | – | – |
| Total assets 5Y CAGR | -24.3% | -14.6% | 283.1% | – | – | – | – | – |
| Total equity 1Y growth | -530.7% | -78.4% | -79.4% | 100.1% | 118.7% | -62.3% | -1,369,943.5% | – |
| Total equity 3Y CAGR | – | -55.4% | – | – | 1,508.2% | – | – | – |
| Total equity 5Y CAGR | – | – | 343.4% | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.